BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260822T141250Z
CREATED:20260822T141250Z
LAST-MODIFIED:20260822T141250Z
UID:10000943-1791417600-1791590399@oncodaily.com
SUMMARY:2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach
DESCRIPTION:The 2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach course\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 8–9\, 2026\, in New York City\, with both in-person and virtual participation available. \nThe two-day program will focus on the latest advances across the full continuum of prostate cancer care\, bringing together experts in urology\, medical oncology\, radiation oncology\, radiology\, and pathology. \nSessions will address patient evaluation and risk assessment\, active surveillance\, focal therapy\, surgery\, radiation therapy\, systemic treatment\, prevention and management of treatment-related side effects\, genomic testing\, biomarkers\, PSMA PET imaging\, and emerging approaches for localized and advanced prostate cancer. \nThe course is intended for urologists\, urologic oncologists\, medical and radiation oncologists\, pathologists\, radiologists\, and allied health professionals\, and participants will receive access after the course to recorded presentations and faculty slides.
URL:https://oncodaily.com/event/advances-in-prostate-cancer-572294
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-06_11_52-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261016T075500
DTEND;TZID=America/Halifax:20261016T150000
DTSTAMP:20260804T175736Z
CREATED:20260804T175653Z
LAST-MODIFIED:20260804T175736Z
UID:10000866-1792137300-1792162800@oncodaily.com
SUMMARY:Benign Hematology and Thrombosis: 2026 Emerging Therapies - MSK
DESCRIPTION:The State of the Art in Benign Hematology\, Hemostasis\, and Thrombosis: 2026 Update in Emerging Therapeutics symposium\, hosted by Memorial Sloan Kettering Cancer Center (MSK)\, will take place in person on 16 October 2026\, from 7:55 a.m. to 3:00 p.m.\, at the Zuckerman Research Center in New York City. \nThe one-day programme will review current and emerging approaches to venous thromboembolism\, pulmonary embolism\, myeloma-associated thrombosis\, factor XI inhibitors\, venous stenting\, post-thrombotic syndrome\, cancer therapy-related cytopenias\, thrombopoietin receptor agonists\, hemophagocytic lymphohistiocytosis\, and immune thrombocytopenia. \nDesigned for hematologists\, oncologists\, advanced practice providers\, trainees\, nurses\, and other healthcare professionals\, the symposium will feature expert presentations\, interactive discussion\, and practical clinical cases. Early registration through 4 September 2026 ranges from $50 to $250\, while general rates range from $100 to $525\, depending on participant category.
URL:https://oncodaily.com/event/benign-hematology-559364
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-09_55_44-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261025
DTSTAMP:20260822T143706Z
CREATED:20260822T143706Z
LAST-MODIFIED:20260822T143706Z
UID:10000944-1792713600-1792886399@oncodaily.com
SUMMARY:2026 Accelerated Review in Medical Oncology
DESCRIPTION:The 2026 Accelerated Review in Medical Oncology\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 23–24\, 2026\, in New York City.  \nThis intensive two-day\, in-person course is designed as a high-yield review for hematology/oncology fellows preparing for initial board certification and medical oncologists preparing for certification or recertification in Medical Oncology. \nThe program will review the diagnosis\, staging\, and management of solid tumors and malignant hematologic disorders\, with particular emphasis on common\, curable malignancies and other high-impact topics frequently tested on the American Board of Internal Medicine (ABIM) examinations. \nContent will be delivered through concise micro-lectures\, and participants will receive a course workbook with summary notes for each topic. The course will conclude with a networking reception on Saturday evening. Virtual participation is not available.
URL:https://oncodaily.com/event/accelerated-review-in-medical-oncology-572301
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-06_36_16-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261028
DTEND;VALUE=DATE:20261030
DTSTAMP:20260822T144649Z
CREATED:20260822T144649Z
LAST-MODIFIED:20260822T144649Z
UID:10000945-1793145600-1793318399@oncodaily.com
SUMMARY:Advancing Surgical Oncology in the Era of Multidisciplinary Cancer Care
DESCRIPTION:The Advancing Surgical Oncology in the Era of Multidisciplinary Cancer Care: Techniques\, Technology\, and Transformation symposium\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 28–29\, 2026\, as a two-day virtual program. \nThe symposium will examine current and emerging advances across surgical oncology\, with expert-led presentations and case-based discussions covering perioperative optimization and management\, minimally invasive surgical approaches\, early surgical recovery\, complex surgical emergencies\, robotics and emerging technologies\, healthcare equity\, workforce development\, and multidisciplinary models of cancer care. \nIt is designed for physicians\, nurse practitioners\, physician assistants\, CRNAs\, nurses\, and other healthcare professionals involved in the management of patients undergoing surgical oncology treatment. \nParticipants may attend the program live online with faculty Q&A and discussion or access the recorded on-demand version through April 30\, 2027. The live activity offers up to 15.00 AMA PRA Category 1 Credits™ and up to 15.00 ABS Continuous Certification/MOC points\, while nursing contact hours are pending.
URL:https://oncodaily.com/event/advancing-surgical-oncology-572324
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-06_45_36-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261030T080000
DTEND;TZID=America/Halifax:20261030T170000
DTSTAMP:20260902T175503Z
CREATED:20260902T175440Z
LAST-MODIFIED:20260902T175503Z
UID:10000990-1793347200-1793379600@oncodaily.com
SUMMARY:2026 Advances in Chronic Graft-Versus-Host Disease
DESCRIPTION:The 2026 Advances in Chronic Graft-Versus-Host Disease: Translating Evidence into Practice conference\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 30\, 2026\, from 8:00 AM to 5:00 PM ET\, at the Zuckerman Research Center in New York City. \nThis one-day\, in-person multidisciplinary programme will focus on improving the understanding and management of adult and pediatric chronic graft-versus-host disease (cGVHD). \nExperts from hematology\, transplantation\, dermatology\, ophthalmology\, gynecology\, pulmonology\, pharmacy\, dentistry\, nutrition\, and supportive care will address the biology of cGVHD\, organ-specific manifestations\, systemic therapy selection and sequencing\, patient-reported outcomes\, oral cancer screening\, pharmacy considerations\, AI-driven clinical data mining\, digital tools for GVHD care\, and development of multidisciplinary GVHD clinics. \nThe programme also includes interactive case discussions\, adult and pediatric management sessions\, a debate on combination therapy\, and a networking reception. Stephanie Lee\, MD\, MPH\, of Fred Hutchinson Cancer Center\, will deliver the keynote address. The activity offers up to 7.25 AMA PRA Category 1 Credits™\, as well as eligible ABIM\, ABP\, and ABS MOC/CC credits. \n 
URL:https://oncodaily.com/event/graft-versus-host-disease-579681
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/GVHD2026_16x9.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261105
DTEND;VALUE=DATE:20261107
DTSTAMP:20260919T202307Z
CREATED:20260919T202307Z
LAST-MODIFIED:20260919T202307Z
UID:10001045-1793836800-1794009599@oncodaily.com
SUMMARY:10th Advances in Colorectal Oncology: Shaping the Future of Multidisciplinary Care
DESCRIPTION:The 10th Advances in Colorectal Oncology: Shaping the Future of Multidisciplinary Care will take place on November 5–6\, 2026\, at Memorial Sloan Kettering Cancer Center (MSK) in New York City\, USA\, with live virtual participation available. The course is organized by Memorial Sloan Kettering Cancer Center and is designed for clinicians involved in the multidisciplinary management of colorectal cancer. \nThis two-day educational program will focus on the latest advances in colorectal cancer diagnosis\, treatment\, and multidisciplinary care. The sessions will address evolving approaches in localized and metastatic colorectal cancer\, surgical management\, systemic therapies\, immunotherapy\, targeted treatments\, molecular profiling\, multidisciplinary decision-making\, and emerging clinical strategies. The program will include expert presentations\, interactive discussions\, and case-based learning designed to translate recent advances into clinical practice.
URL:https://oncodaily.com/event/advances-in-colorectal-oncology-589297
LOCATION:Memorial Sloan Kettering Cancer Center\, 1275 York Avenue\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-20-2026-12_17_13-AM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261206
DTSTAMP:20260920T195710Z
CREATED:20260920T195710Z
LAST-MODIFIED:20260920T195710Z
UID:10001050-1796342400-1796515199@oncodaily.com
SUMMARY:Emergencies in the Cancer Patient 2026
DESCRIPTION:The Emergencies in the Cancer Patient 2026 will take place from December 4–5\, 2026\, at Memorial Sloan Kettering Cancer Center (MSK) in New York City\, USA\, with virtual and on-demand participation available. \nThe course is organized by Memorial Sloan Kettering Cancer Center and focuses on the recognition and management of acute complications in patients with cancer. \nThis multidisciplinary program will address the diagnosis and treatment of oncologic emergencies and acute complications throughout the cancer journey. Topics include hematologic emergencies\, central nervous system emergencies\, infections and sepsis\, metabolic complications\, pain crises\, surgical emergencies\, complications related to transplantation\, immune-related adverse events\, and toxicities associated with modern cancer therapies. The course is designed to provide practical approaches for clinicians managing complex cancer patients in urgent settings.
URL:https://oncodaily.com/event/cancer-patient-590287
LOCATION:Memorial Sloan Kettering Cancer Center\, 1275 York Avenue\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-20-2026-11_53_24-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261214
DTSTAMP:20260920T200621Z
CREATED:20260920T200621Z
LAST-MODIFIED:20260920T200621Z
UID:10001051-1797033600-1797206399@oncodaily.com
SUMMARY:Diagnostic Excellence Across the Cancer Care Continuum: Screening\, Early Detection\, Complications and Survivorship
DESCRIPTION:The Diagnostic Excellence Across the Cancer Care Continuum: Screening\, Early Detection\, Complications and Survivorship will take place on December 12–13\, 2026\, at Memorial Sloan Kettering Cancer Center (MSK) in New York City\, USA\, with virtual and on-demand participation available. \nThe program is organized by Memorial Sloan Kettering Cancer Center and focuses on improving diagnostic approaches across the entire cancer care pathway. \nThis multidisciplinary educational program will explore advances in cancer screening\, early detection\, diagnostic pathways\, treatment-related complications\, and survivorship care. \nSessions will address topics including optimizing screening strategies\, improving diagnostic accuracy\, evaluation of incidental findings\, reducing diagnostic delays\, managing complications after cancer treatment\, and supporting long-term survivorship care. The course is designed for clinicians and healthcare professionals involved in improving cancer outcomes through earlier and more accurate diagnosis.
URL:https://oncodaily.com/event/cancer-care-continuum-590296
LOCATION:Memorial Sloan Kettering Cancer Center\, 1275 York Avenue\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-21-2026-12_05_38-AM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20270224T090000
DTEND;TZID=America/Halifax:20270224T170000
DTSTAMP:20260829T230210Z
CREATED:20260829T230125Z
LAST-MODIFIED:20260829T230210Z
UID:10000974-1803459600-1803488400@oncodaily.com
SUMMARY:The 2027 Translating Evidence to Action: Elevating Cancer Care Conference
DESCRIPTION:The 2027 Translating Evidence to Action: Elevating Cancer Care conference\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place virtually on February 24\, 2027\, from 9:00 AM to 5:00 PM ET. \nDesigned for healthcare professionals across disciplines\, the annual forum focuses on translating high-quality evidence into everyday clinical practice and will feature more than 20 quality-improvement projects and practice initiatives. Project leaders will share practical strategies for implementing evidence-based change\, demonstrating measurable improvements in care\, managing change\, evaluating return on investment\, and integrating research findings into routine practice. \nFeatured speakers include Darcy Burbage\, DNP\, RN\, AOCN\, Oncology Clinical Nurse Specialist and Consulting Associate at Duke University School of Nursing\, and Ophelia Chiu\, Vice President of Strategic Innovation at MSK. The activity has been approved for AMA PRA Category 1 Credit™\, while an application for ANCC nursing contact hours is pending.
URL:https://oncodaily.com/event/elevating-cancer-care-577380
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/1782146411582.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
LOCATION:
END:VEVENT
END:VCALENDAR